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Purpose: Swellable microspheres based on polymers or their admixtures are frequently employed as 
drug delivery systems to achieve a controlled release and site-specific targeting of the incorporated 
drug. The objective of the present study was to enhance the rectal delivery of cefuroxime sodium by 
entrapping it into water-swellable gelatin-mucin microspheres. 
Method: Cefuroxime sodium-loaded microspheres containing admixtures of gelatin and porcine mucin 
were prepared via an emulsification-crosslinking technique. The drug entrapment efficiency of the 
microspheres was evaluated in citrate/phosphate buffer (pH 7.4) while the swelling properties was 
evaluated in both simulated gastric fluid (SGF) without pepsin and simulated intestinal fluid (SIF) without 
pancreatin (pH 1.2). Release of cefuroxime sodium from the microspheres was evaluated in vitro in SIF 
and further evaluated in vivo after rectal administration to male Wistar rats. 
Result: Results obtained showed that a high entrapment efficiency, most notably manifested in 
microspheres formulated with equal portions of gelatin and mucin, led to a high release (up to 85 %) and 
also a high bioavailability of the incorporated drug. Formulations based on varying portions of gelatin 
and mucin also showed high drug loading efficiency which also resulted in high drug release in SIF 
within 3 h. Drug release from the different formulations was observed to be rapid and generally showed 
a biphasic pattern. The mean AUC was shown to be formulation-dependent with values of 
168±1.93µg.h/ml for the control, 262±3.47 µg.h/ml for microspheres based on gelatine only and 
328±2.55 µg.h/ml for microspheres formulated with equal parts of gelatin and mucin.  
Conclusion: The inclusion of S-mucin in the composition of the microspheres has an enhancer effect 
on the release and rectal bioavailability of cefuroxime sodium which may be exploited in the design of a 
rectal delivery system of the drug. 
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INTRODUCTION 
The rectal route has been frequently exploited 
for the systemic delivery of drugs in situations 
where it is desirable to avoid hepatic first-pass 
metabolism1 or to prolong drug release2. For 
effective retention of medication on the rectal 
mucosa, the drug delivery system should display 
a mucoadhesive property. 
Microspheres have been extensively studied for 
use as drug delivery systems, where they have 
been shown to protect sensitive macromolecules 
from enzymatic and acid degradation, and allow 
controlled release and tissue targeting of the 
formulated drug 3-13. Microspheres prepared with 
gelatin as the polymer have been found to be 
highly mucoadhesive and have been used for 
the controlled release of many drugs 14. 
Microspheres prepared from admixtures of 
gelatin and crosslinked chitosan demonstrated 
some advantage over that prepared from gelatin 
alone in terms of better controlled release rate of 
cimetidine 14.  The reported ionic interaction of 
mucin with many biologically important 
compounds including polymers 15 suggested that 
mucoadhesive microspheres could be produced 
from admixtures of mucin and gelatin. The 
parenteral route of administration of antibiotics 
(including cefuroxime sodium) is fraught with 
myriad of draw-backs especially pain at the 
injection site which often leads to poor patient 
compliance or complete non-compliance with its 
obvious consequences. The rectal route of 
administration of cefuroxime sodium could, 
therefore, offer   better advantages in terms of 
enhanced patient compliance and could also be 
a potential alternative to the parenteral route for 
the delivery of cefuroxime sodium. 
 
The search for alternative routes of delivery of 
many drugs including insulin and other peptides 
is continuing; hence our current efforts to explore 
the rectal route for the delivery of cefuroxime 
sodium, an acid labile cephalosporin. The 
objective of this study was to develop 
mucoadhesive formulations (microspheres) 
based on gelatin and its admixtures with porcine 
mucin with a view to enhancing the rectal 
delivery of cefuroxime sodium through 
entrapment into these microspheres. This way, a 
viable alternative route of delivery of cefuroxime 
sodium, in addition to the parenteral route, would 
have been provided. 
 
MATERIALS AND METHODS 
Materials 
Cefuroxime sodium powder (GlaxoWellcome, 
England); citric acid, sodium hydroxide (Merck, 
Germany); acetone, concentrated HCl, 
glutaraldehyde, disodium hydrogen phosphate, 
sodium chloride (BDH, England); type A gelatin 
(75 bloom), monobasic potassium phosphate 
(Sigma Chemical Co., USA) were used as 
procured from the manufacturers without further 
purification.  All other reagents were analytical 
grade and used as such.  Distilled water was 
obtained from an all-glass still. The animal 
experimental protocols were approved by our 
institution’s Animal Ethics Committee. 
Isolation of the porcine mucin 
The small intestines of freshly slaughtered pigs 
(within 1 h post mortem) were obtained from the 
abattoir of the Animal Science Department in our 
University and dissected, starting from the 
jejunum to the ileocaecal sphincter.  The 
intestines, sectioned into short lengths, were 
flushed through with chilled saline, and the 
mucosal surface was exposed by longitudinal 
dissection.  By using a microscope slide, the 
mucus layer was gently scraped off and diluted 
with four times its volume of distilled water.  The 
gel was homogenized for 2 h at 4 oC and 
thereafter exhaustively dialysed against distilled 
water using a 12 KDa molecular weight cut-off 
(MWCO) dialysis membrane.  The dialysate was 
finally centrifuged at 10,000 rpm for 30 min to 
yield a supernatant of water-soluble mucus 
glycoprotein layers and lower layer of insoluble 
mucus glycoprotein. The supernatants were 
collected separately, pooled and lyophilized at -
40oC for 48 h to obtain flakes of soluble (S) 
mucin, which were powdered and used for the 
study. 
Preparation of gelatin-mucin admixtures 
1 g quantity of gelatin was dispersed in 50 ml of 
citrate/phosphate buffer of pH 3.4.  An equal 
amount of S-mucin was similarly weighed out 
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and mixed thoroughly with the dispersion of 
gelatin in a beaker.  The mixture was left to 
stand for 24 h in order to attain maximum 
hydration.  It was then homogenized by stirring 
with a glass rod for 5min. The procedure was 
repeated to obtain S-mucin to gelatin in ratios of 
1:1, 1:2, 1:3, and 1:4.   
Preparation of the gelatin-mucin 
microspheres 
A dispersion of each gelatin-mucin admixture (25 
% v/v in arachis oil) was used in the preparation 
of the microspheres. 1 g of cefuroxime sodium 
powder was dispersed in 25 ml of  the gelatin-
mucin dispersion and heated until the 
temperature of the dispersion was brought to 40 
oC.  The dispersion was further extruded 
dropwise, with the aid of a syringe into pure 
arachis oil maintained at 40 oC on a 
thermostatically controlled hot plate-magnetic 
stirrer.  The mixture was stirred at a speed of 
500 rpm for 30 min. Glutaraldehyde was added 
to a concentration of about 1 % v/v to cross-link 
the microspheres in situ and stirred further for 30 
min.  The resulting mixture was centrifuged at 
6000 rpm for 10 min to collect the microspheres.  
The microspheres collected were washed with 
acetone to remove excess oil and then dried at 
the ambient temperature of 28 ± 2 oC. 
 
Determination of entrapment efficiency of the 
microspheres 
A quantity (100 mg) of the microspheres was  
placed in a beaker containing 100 ml of the  
citrate/phosphate buffer (pH 7.4) The dispersion 
was vortexed repeatedly to break up the 
microspheres and cause them to discharge their 
drug contents completely. The solution was then 
filtered and analyzed spectrophotometrically at a 
wavelength of 280 nm using a UV-Vis 
spectrophotometer (Spectronic 21D).  The drug 
concentration in each batch of the microspheres 
was calculated from a Beer’s plot previously 
determined for cefuroxime sodium.  An average 
of five determinations was taken as the mean 
drug content for each batch of microspheres. 
 
In vitro drug release studies 
The USP XXVII paddle method was adopted in 
this study.  The release medium consisted of 
500 ml of freshly prepared SIF (pH 7.4) 
maintained at 37 ± 1 oC. SIF was selected as the 
release medium since it has a pH very close to 
that of the rectal fluids.  A known quantity (100 
mg) of each batch of the microspheres was 
placed in the appropriate chamber of the release 
apparatus and agitated at 100 rpm. At 
predetermined time intervals, 1 ml aliquots of the 
release medium were withdrawn, appropriately 
diluted and assayed spectrophotometrically at 
280 nm.  At every interval, 1 ml of fresh SIF was 
added to replace the sample that was withdrawn.  
The concentrations of the withdrawn samples 
were calculated with reference to the standard 
Beer’s plot. Four replicate release studies were 




Male Wistar rats aged two months with a mean 
weight of 200 ± 10.5 g were obtained from the 
Department of Veterinary Pathology and 
Microbiology, of our University and used for the 
study.  The rats were allowed to acclimatize to 
the new environmental conditions of our 
laboratories for one week before use.  Three 
groups of eight animals each  were used for the 
study.  An amount of the microspheres 
equivalent to a dose of 100 mg of the drug/kg 
body weight of the rats was carefully transferred 
into the empty bodies of capsule no. 3. A 
positive control was set up by enclosing an equal 
amount of the pure cefuroxime sodium powder 
equivalent to that in the microspheres.  By 
means of the capsules the drug was 
administered rectally to the rats.  At regular time 
intervals of 30 min for the first one hour, and 
then subsequently at 1 h intervals, 0.5 ml of 
blood samples were withdrawn from the orbital 
sinus of the rat 16,17. 
 
Analysis of cefuroxime sodium in protein-
free rat plasma 
The method of Tietz 18 was adopted to prepare a 
protein-free filtrate. The blood sample (0.2 ml) 
was added to a test-tube containing 1.8 ml of 3 
% trichloroacetic acid (TCA).  The test-tube was 
shaken gently to ensure proper mixing and 
allowed to stand for 5–10 min.  The test-tube 
was further centrifuged for 10 min at 3000 rpm 
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after which 1 ml of the clear supernatant layer 
was collected and analyzed 
spectrophotometrically without dilution at 280 
nm. The blank was a 3 % solution of TCA. An 
absorption spectrum previously constructed for a 
solution of cefuroxime sodium in TCA did not 
show any shift from the earlier wavelength of 
maximum absorption; an indication that no 
significant interaction occurred between the two 
compounds (i.e. TCA and cefuroxime sodium).  
Statistical data analysis  
Statistical data analysis were performed using 
the student’s t-test with p ≤ 0.05 as the minimal 




The results of the water sorption studies carried 
out in two different media(SIF and SGF) are 
shown in Figs. 1 and 2. It can be seen from 
these figures that microspheres prepared from 
admixtures of gelatin and S-mucin showed 
higher swelling tendency especially in SGF 
where between 35 and 82 % water sorption was 
recorded when compared to that prepared from 
gelatin only which showed a water sorption of 25 
%. Water sorption for all the batches of 
microspheres including that formulated with 
gelatin only was quite high in SIF and ranged 
between 150 and 290 %. The highest water 
sorption capacity was shown by microspheres 
formulated with equal portions of gelatin and 
mucin and this was followed closely by  
Table 1: Release kinetic parameters of cefuroxime sodium from the microspheres in SIF  
 
Release parameters Microsphere 
(mucin-
gelatin ratio) 
n K r  
1:1 0.50 0.1931 0.9965 
1:2 0.48 0.1983 0.9881 
1:3 0.96 0.2214 0.9915 
1:4 0.82 0.2651 0.9853 
Gelatin 
alone 
0.57 0.3273 0.9855 
n = Release exponent; K = Release kinetic constant; r = Correlation coefficient 
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Fig. 4: Plasma cefuroxime sodium versus time profile for the microspheres 
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microspheres based on gelatin only. Water 
absorption and the rate of water absorption by 
the microspheres followed the order:1:1 > 1:2 > 
1:3 > 1:4 > gelatin alone in SGF while the order 
in SIF is;1:4 > gelatin alone > 1:3 > 1:2 > 1:1.               
 
The drug entrapment efficiency was observed to 
be dependent on the composition of the 
microspheres. Microspheres prepared from 
combinations of gelatin and S-mucin entrapped 
greater amounts (p ≤ 0.05) of cefuroxime sodium 
in comparison with those prepared from gelatin 
alone.  The drug entrapment efficiency of all 
batches of the microspheres was in the range of 
72.6 to 98.4 % with microspheres formulated 
with gelatin-mucin (1:1) recording the highest 
drug entrapment. The general pattern was that 
drug entrapment decreased with increasing 
proportions of gelatin in the gelatin-mucin 
admixtures used in preparing the microspheres. 
 
The release profile of cefuroxime sodium from 
the microspheres in SIF is shown in Fig. 3. 
There was an initial rapid release of cefuroxime 
sodium from the microspheres in SIF within 30 
min and this was followed by a much slower 
release over the next 150 min. Drug release was 
highest from microspheres prepared with equal 
proportions of S-mucin and gelatin (1:1) where 
up to 85 % of the drug was released within 3 h. 
A characteristic feature of the release profile of 
cefuroxime sodium from the microspheres in  
SIF  is the biphasic pattern of release.   
 
The plasma concentration versus time curves for 
cefuroxime sodium, after rectal administration to 
male Wistar rats, are depicted in Fig. 4.  The 
areas under the plasma level versus time curves 
(AUC) were evaluated using the trapezoid rule 
based on a non-compartmental pharmacokinetic 
analysis. The pharmacokinetic parameters as 
can be seen from Fig. 4 showed a higher peak 
plasma concentration of 4.5±0.39 µg/ml for 
microspheres based on gelatin-mucin in the ratio 
1:1 when compared to that for the control 
(3.5±0.45 µg/ml) or the microspheres based on 
gelatin only (4.0±0.45 µg/ml). The mean AUC 
was shown to be dependent on the formulation 
with values of 168±1.93 µg.h/ml for the control  , 
262±3.47 µg.h/ml for microspheres based on 
gelatin only and 328±2.55 µg.h/ml for 
microspheres formulated with gelatin and mucin 
in the ratio 1:1 which gives an indication that the 
inclusion of mucin in the microsphere formulation 




The water sorption behaviour in the two media 
may be an indication of a probable modification 
of the gelatin microspheres by the mucin. The 
higher amount and rate of water absorption in 
SIF than in SGF may also be attributable to the 
type of gelatin (type A) used in preparing the 
microspheres. This type of gelatin is known to be 
produced from acidic precursors and would, 
therefore, be expected to swell more in an 
alkaline environment of the SIF than in SGF.  
 
The wide variation in the drug contents of the 
different batches of the microspheres could be a 
consequence of the varying degrees of drug 
sedimentation and the relative partitioning of 
cefuroxime sodium between the dispersed and 
continuous phases of the emulsion prior to 
cross-linking of the polymer admixtures. 
 
The rapid release in the first 30 min as is evident 
in Fig. 3 is possibly due to a burst effect caused 
by the leaching out of the unentrapped drug 
adhering to the surface of the microspheres after 
the initial rapid hydration and swelling. The high 
and rapid release of cefuroxime sodium from the 
microspheres in SIF, in addition to the burst 
effect, may also may be a result of the high rate 
of hydration and swelling of the microspheres in 
SIF , which, in turn, could be, attributable to the 
type of gelatin (type A) used in preparing the 
microspheres. The subsequent slow release 
phase could be a consequence of the 
decreasing residual amount of drug in the 
microspheres and the build-up of drug 
concentration in the dissolution medium in the 
course of time. This indicates that once the drug 
adhering to the microspheric surface has 
leached, the drug release obeys the Higuchi 
membrane diffusion controlled model 19. 
 Further analysis of the release of cefuroxime 
sodium from the microspheres was done using 
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the Fickian diffusion model 20 to determine the 
mechanism of release.  To understand the  
release mechanism of cefuroxime sodium from 
the microspheres, the release rate was 








Mlog t +=     (2) 
Mt/M is the fraction of drug released at time t, K 
is a kinetic constant that incorporates the 
structural and geometric characteristics of the 
release device and n is the release exponent 
indicative of the mechanism of release.  An n 
value of 1.0 corresponds to zero-order release 
kinetics (case-II transport).  An n value greater 
than 0.5 but less than 1.0 means an anomalous 
(non-Fickian) diffusion release model; n = 0.5 
indicates Fickian diffusion while n > 1.0 indicates 
a super case-II relaxational release 21.  The 
kinetic parameters, n and K as calculated from 
plots of log Mt/M versus log t for cefuroxime 
sodium are presented in Table 1 where can be 
seen that  the values of the release exponent, n, 
were in the range 0.48 to 0.96, indicating that the 
release of cefuroxime sodium from the 
microspheres in SIF occurred predominantly by 
diffusion following an initial non-Fickian 
transport.   
 
Compared with the control and microspheres 
formulated with gelatin only, it is interesting to 
note that the bioavailability of cefuroxime sodium 
via the rectal route was higher (AUC = 328 µg.h 
ml-1) from microspheres formulated with an 
admixture of S-mucin and gelatin in the ratio 1:1. 
The in vitro release study in  SIF showed that 
higher amount of cefuroxime sodium was 
released from the 1:1 mucin-gelatin based 
microspheres than from gelatin-only based 
microspheres.  There is, therefore, a correlation 
between the in vitro release and in vivo 
availability. Interestingly, the peak plasma 
concentration followed a pattern closely similar 
to the AUC and this provided a further index of 
the bioavailability of the drug studied.  The 
generally high AUC values obtained for the 
microspheres may be an indication that the 
absorption of cefuroxime sodium was both rapid 
and complete and that the drug may have by-
passed the hepatic first-pass metabolism.  It is 
noteworthy to point out that adequate 
precautions were taken to deposit the 
encapsulated microspheres on the lower or 
middle part of the rat’s rectum with the 
expectation of causing the absorbed drug to 
drain directly into the general circulation via 
either the lower or middle haemorrhoidal veins.  
This expectation may have been realized 
considering the high AUC values obtained for 
the microspheres. It is also deducible from Fig. 4 
that the bioavailability as well as the time to 
attain peak peak plasma level for cefuroxime 
sodium was generally higher from the 
microspheres in comparison with that of the 
control.  
CONCLUSION 
The results have shown that the entrapment of 
cefuroxime sodium in gelatin-mucin 
microspheres can be used to improve the rectal 
delivery of the drug. Thus, the findings may be 
exploited in the design of a rectal delivery 
system for the drug. 
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